According to a team of clinician-researchers and neuroscientists, individuals with treatment-resistant major depressive disorder (MDD) can benefit from accelerated regimens for repeated transcranial magnetic stimulation (rTMS).
Accelerated schedules for repetitive transcranial magnetic stimulation (rTMS) can be offered to patients experiencing treatment-resistant major depressive disorder (MDD), a group of clinician–researchers and neuroscientists have concluded. The group cautions that such treatment should be proposed only after detailed discussion with patients about acceleration being an alternate form of rTMS scheduling, with documentation of informed consent.